Image
  • Home
  • PrEP Guidelines
    • Introduction
    • PrEP in Australia
    • Behavioural suitability for PrEP
    • Clinical assessment before starting PrEP
    • Providing PrEP
    • Clinical follow-up and monitoring of patients on PrEP
    • Special clinical considerations
    • NPEP and PrEP
    • Improving medication adherence
  • About
    • Glossary of terms
    • Acknowledgements
    • Disclosure statement
    • Feedback
    • Bookmarks
  • Resources
    • Health Professional resources
    • Patient resources
  • Contact Us
Clinical assessment

Introduction

PrEP safety and efficacy

PRINT AS PDF

For a full review of PrEP safety and efficacy please see the CDC “Pre-exposure prophylaxis for

The prevention of hiv Infection in the united states– 2017 update” starting from page 16.

https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf

READ NEXT: References

sections

  • Introduction
  • Key recommendations of the ASHM PrEP Guidelines Panel
  • On-demand† PrEP is contraindicated in people with chronic hepatitis B infection
  • PrEP safety and efficacy
  • References

DOWNLOAD


Full PrEP guidelines
PrEP decision making tool
ASHM

ABOUT

About ASHM
Glossary of terms
Acknowledgements
Disclosure statements
Feedback
Privacy Policy

RESOURCES

Health Professional resources
Patient resources

COPYRIGHT © ASHM 2019

  • Home
  • PrEP Guidelines
    • Introduction
    • PrEP in Australia
    • Behavioural suitability for PrEP
    • Clinical assessment before starting PrEP
    • Providing PrEP
    • Clinical follow-up and monitoring of patients on PrEP
    • Special clinical considerations
    • NPEP and PrEP
    • Improving medication adherence
  • About
    • Glossary of terms
    • Acknowledgements
    • Disclosure statement
    • Feedback
    • Bookmarks
  • Resources
    • Health Professional resources
    • Patient resources
  • Contact Us